Daphne Haim-Langford is a prominent figure in the biopharmaceutical industry. She holds a PhD in Biophysics from Technion - Israel Institute of Technology, and has since gone on to co-found and serve in executive roles in several successful startups in the field. As the founder and CEO of Tarsier Pharma, she leads a team dedicated to developing innovative drug therapies. Prior to this, she served as a board member at Omnix Medical, Eximore Ltd., Medi-Tate, keepMED Ltd., and Orthospace Ltd. She has also worked in business development at several biotech companies, including Cellect Biotech, Medingo, and PerAsist. Haim-Langford's expertise in biophysics and her leadership in the field of biopharmaceuticals make her a highly regarded professional.